NASDAQ:ZGNX - Zogenix News Headlines

Sign in or create an account to add this stock to your watchlist.
$58.95 -0.25 (-0.42 %)
(As of 07/19/2018 04:00 PM ET)
Previous Close$59.20
Today's Range$57.75 - $59.35
52-Week Range$10.05 - $62.75
Volume624,770 shs
Average Volume622,933 shs
Market Capitalization$2.15 billion
P/E Ratio-14.65
Dividend YieldN/A
Beta1.83

Headlines

Zogenix (NASDAQ ZGNX) News Headlines

Source:
DateHeadline
Zogenix, Inc. (ZGNX) Expected to Announce Earnings of -$0.90 Per ShareZogenix, Inc. (ZGNX) Expected to Announce Earnings of -$0.90 Per Share
www.americanbankingnews.com - July 16 at 2:12 PM
Zogenix (ZGNX) in Focus: Stock Moves 9.8% HigherZogenix (ZGNX) in Focus: Stock Moves 9.8% Higher
www.zacks.com - July 16 at 8:25 AM
Todays Research Reports on Trending Tickers: Zogenix and Momenta PharmaceuticalsToday's Research Reports on Trending Tickers: Zogenix and Momenta Pharmaceuticals
finance.yahoo.com - July 16 at 8:25 AM
Zogenix (ZGNX) Given New $65.00 Price Target at Stifel NicolausZogenix (ZGNX) Given New $65.00 Price Target at Stifel Nicolaus
www.americanbankingnews.com - July 15 at 4:25 AM
Zogenix, Inc. (ZGNX) PT Raised to $65 at Stifel Following Phase 3 ZX008 ResultsZogenix, Inc. (ZGNX) PT Raised to $65 at Stifel Following Phase 3 ZX008 Results
www.streetinsider.com - July 14 at 4:11 PM
Why Zogenix Inc. Shares Jumped 10% on FridayWhy Zogenix Inc. Shares Jumped 10% on Friday
finance.yahoo.com - July 14 at 4:11 PM
Zogenix Soars On Positive Phase 3 Data In Dravet Syndrome StudyZogenix Soars On Positive Phase 3 Data In Dravet Syndrome Study
www.benzinga.com - July 14 at 4:11 PM
Zogenixs Epilepsy Candidate Successful in Phase III StudyZogenix's Epilepsy Candidate Successful in Phase III Study
finance.yahoo.com - July 14 at 4:11 PM
Why Twitter, Papa Johns International, and Zogenix Jumped TodayWhy Twitter, Papa John's International, and Zogenix Jumped Today
www.fool.com - July 13 at 4:11 AM
Zogenix Inc. (ZGNX) Has Broken Out To A New High On Study ResultsZogenix Inc. (ZGNX) Has Broken Out To A New High On Study Results
www.nasdaq.com - July 12 at 4:33 PM
Zogenix (ZGNX) Reports Positive Top-Line Results from Second Pivotal Phase 3 Clinical Trial of ZX008 in Dravet SyndromeZogenix (ZGNX) Reports Positive Top-Line Results from Second Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome
www.streetinsider.com - July 12 at 4:33 PM
Zogenix Stock Soars on Positive Clinical Trial ResultsZogenix Stock Soars on Positive Clinical Trial Results
finance.yahoo.com - July 12 at 4:33 PM
Mid-Afternoon Market Update: Dow Up Over 200 Points; Zogenix Shares Gain On Positive Phase 3 Data In Dravet Syndrome StudyMid-Afternoon Market Update: Dow Up Over 200 Points; Zogenix Shares Gain On Positive Phase 3 Data In Dravet Syndrome Study
feeds.benzinga.com - July 12 at 3:31 PM
Why Zogenix Inc. Is Soaring TodayWhy Zogenix Inc. Is Soaring Today
www.fool.com - July 12 at 3:13 PM
Zogenix (ZGNX) Stock Soars on Anti-Seizure Drug ResultsZogenix (ZGNX) Stock Soars on Anti-Seizure Drug Results
investorplace.com - July 12 at 1:21 PM
Zogenix (ZGNX) PT Raised to $69.00Zogenix (ZGNX) PT Raised to $69.00
www.americanbankingnews.com - July 12 at 1:20 PM
Zogenixs ZX008 successful in second late-stage study in DravetZogenix's ZX008 successful in second late-stage study in Dravet
seekingalpha.com - July 12 at 8:37 AM
ZGNX Hits All-time High On Positive Dravet Syndrome Drug ResultsZGNX Hits All-time High On Positive Dravet Syndrome Drug Results
www.nasdaq.com - July 12 at 8:37 AM
Zogenix shares soar 19% premarket after news of positive trial for severe epilepsy treatmentZogenix shares soar 19% premarket after news of positive trial for severe epilepsy treatment
www.marketwatch.com - July 12 at 8:37 AM
Benzingas Daily Biotech Pulse: Acceleron On Fast Lane, OncoCytes Accurate Diagnosis, Inspire Medical Gets Aetna ...Benzinga's Daily Biotech Pulse: Acceleron On Fast Lane, OncoCyte's Accurate Diagnosis, Inspire Medical Gets Aetna ...
www.benzinga.com - July 10 at 8:43 AM
Zogenix, Inc. (ZGNX) Receives Average Rating of "Buy" from BrokeragesZogenix, Inc. (ZGNX) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - July 4 at 6:41 AM
New global chief commercial officer for ZogenixNew global chief commercial officer for Zogenix
seekingalpha.com - July 2 at 4:30 PM
Zogenix Welcomes New Global Chief Commercial OfficerZogenix Welcomes New Global Chief Commercial Officer
finance.yahoo.com - July 2 at 8:52 AM
The Week Ahead In Biotech: Delayed Clinical Trial Releases In FocusThe Week Ahead In Biotech: Delayed Clinical Trial Releases In Focus
feeds.benzinga.com - June 30 at 7:27 PM
-$0.90 Earnings Per Share Expected for Zogenix, Inc. (ZGNX) This Quarter-$0.90 Earnings Per Share Expected for Zogenix, Inc. (ZGNX) This Quarter
www.americanbankingnews.com - June 28 at 3:08 AM
Contrasting Zogenix (ZGNX) & Its PeersContrasting Zogenix (ZGNX) & Its Peers
www.americanbankingnews.com - June 27 at 10:08 AM
US approves first marijuana plant-derived drug for epilepsyUS approves first marijuana plant-derived drug for epilepsy
www.reuters.com - June 25 at 5:07 PM
Head-To-Head Analysis: Zogenix (ZGNX) & Its CompetitorsHead-To-Head Analysis: Zogenix (ZGNX) & Its Competitors
www.americanbankingnews.com - June 24 at 11:12 PM
Head to Head Comparison: Zogenix (ZGNX) & The CompetitionHead to Head Comparison: Zogenix (ZGNX) & The Competition
www.americanbankingnews.com - June 21 at 7:12 PM
Commit To Purchase Zogenix At $30, Earn 19.7% Using OptionsCommit To Purchase Zogenix At $30, Earn 19.7% Using Options
www.nasdaq.com - June 15 at 5:03 PM
Zogenix, Inc. (ZGNX) EVP Sells $230,310.00 in StockZogenix, Inc. (ZGNX) EVP Sells $230,310.00 in Stock
www.americanbankingnews.com - June 13 at 10:34 PM
Zogenix (ZGNX) & GW Pharmaceuticals (GWPH) Head-To-Head ContrastZogenix (ZGNX) & GW Pharmaceuticals (GWPH) Head-To-Head Contrast
www.americanbankingnews.com - June 11 at 3:18 AM
-$0.90 EPS Expected for Zogenix (ZGNX) This Quarter-$0.90 EPS Expected for Zogenix (ZGNX) This Quarter
www.americanbankingnews.com - June 11 at 1:28 AM
Reviewing Zogenix (ZGNX) and Its CompetitorsReviewing Zogenix (ZGNX) and Its Competitors
www.americanbankingnews.com - June 10 at 9:26 PM
Analyzing Zogenix (ZGNX) & Its RivalsAnalyzing Zogenix (ZGNX) & Its Rivals
www.americanbankingnews.com - June 10 at 5:20 PM
Zogenix (ZGNX) Given Consensus Rating of "Buy" by AnalystsZogenix (ZGNX) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - June 9 at 5:38 AM
Zogenix (ZGNX) versus The Competition Head to Head ComparisonZogenix (ZGNX) versus The Competition Head to Head Comparison
www.americanbankingnews.com - June 6 at 3:28 PM
This Cannabis-Based Drug Is On the Verge of Making HistoryThis Cannabis-Based Drug Is On the Verge of Making History
finance.yahoo.com - May 28 at 8:57 AM
Reader Inquiry: Is There Further Upside In Zogenix?Reader Inquiry: Is There Further Upside In Zogenix?
seekingalpha.com - May 26 at 4:43 PM
Zogenix, Inc. (ZGNX) Given Average Recommendation of "Buy" by AnalystsZogenix, Inc. (ZGNX) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - May 15 at 5:34 AM
Zogenix to Participate in the Bank of America Merrill Lynch 2018 Healthcare ConferenceZogenix to Participate in the Bank of America Merrill Lynch 2018 Healthcare Conference
globenewswire.com - May 14 at 9:10 AM
Leerink Swann Equities Analysts Lower Earnings Estimates for Zogenix, Inc. (ZGNX)Leerink Swann Equities Analysts Lower Earnings Estimates for Zogenix, Inc. (ZGNX)
www.americanbankingnews.com - May 14 at 1:17 AM
Q2 2018 EPS Estimates for Zogenix, Inc. Lowered by Analyst (ZGNX)Q2 2018 EPS Estimates for Zogenix, Inc. Lowered by Analyst (ZGNX)
www.americanbankingnews.com - May 14 at 1:17 AM
Research Analysts Offer Predictions for Zogenix, Inc.s FY2021 Earnings (ZGNX)Research Analysts Offer Predictions for Zogenix, Inc.'s FY2021 Earnings (ZGNX)
www.americanbankingnews.com - May 11 at 11:47 AM
Zogenix (ZGNX) Releases  Earnings Results, Misses Estimates By $0.13 EPSZogenix (ZGNX) Releases Earnings Results, Misses Estimates By $0.13 EPS
www.americanbankingnews.com - May 10 at 6:33 PM
Zogenixs (ZGNX) "Buy" Rating Reiterated at MizuhoZogenix's (ZGNX) "Buy" Rating Reiterated at Mizuho
www.americanbankingnews.com - May 10 at 11:28 AM
Zogenixs (ZGNX) CEO Stephen Farr on Q1 2018 Results - Earnings Call TranscriptZogenix's (ZGNX) CEO Stephen Farr on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 8:56 AM
Edited Transcript of ZGNX earnings conference call or presentation 9-May-18 8:30pm GMTEdited Transcript of ZGNX earnings conference call or presentation 9-May-18 8:30pm GMT
finance.yahoo.com - May 10 at 8:56 AM
BRIEF-Zogenix Q1 Loss Per Share $0.87BRIEF-Zogenix Q1 Loss Per Share $0.87
www.reuters.com - May 9 at 5:06 PM
Zogenix Provides Corporate Update and Reports First Quarter Financial ResultsZogenix Provides Corporate Update and Reports First Quarter Financial Results
finance.yahoo.com - May 9 at 5:06 PM
This page was last updated on 7/19/2018 by MarketBeat.com Staff

Featured Article: Short Selling

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.